How a Predictive Biosciences Firm Validated Its AI Model Using Expert-Labeled Clinical Narratives

Cogito16 May, 2025Technology

A leading predictive biotechnology research company developing AI-powered models for drug toxicity sought to evaluate whether its in silico systems could accurately detect Drug-Induced Liver Injury (DILI) using real-world clinical narratives, 2D molecular structure data, and high-content imaging. However, early model development was hindered by inconsistent image annotations, which introduced ambiguity in key cytotoxic phenotypes such as ER stress and cell death. These inconsistencies limited both the model’s accuracy and its interpretability.